论文部分内容阅读
美国纽约大学医学院的Chuan ju Liu等研发了一种能用于治疗类风湿性关节炎的蛋白,从而为治疗这种自身免性疾病提供新的治疗靶标。研究人员发现一种生长因子PGRN能与肿瘤坏死因子TNFR直接结合,从而扰乱TN-
Chuan ju Liu et al at the New York University School of Medicine in the United States have developed a protein that can be used to treat rheumatoid arthritis to provide new therapeutic targets for the treatment of this autoimmune disease. The researchers found that a growth factor PGRN can bind directly to tumor necrosis factor TNFR, thereby disrupting TN-